TD Cowen Maintains Buy on Addus HomeCare, Raises Price Target to $137
Portfolio Pulse from Benzinga Newsdesk
TD Cowen analyst Ryan Langston maintains a Buy rating on Addus HomeCare (NASDAQ:ADUS) and raises the price target from $128 to $137.
August 08, 2024 | 6:03 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
TD Cowen analyst Ryan Langston maintains a Buy rating on Addus HomeCare and raises the price target from $128 to $137.
The raised price target and maintained Buy rating from a reputable analyst suggest a positive outlook for Addus HomeCare, likely leading to a short-term increase in stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100